What is the recommended treatment for croup in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Croup in Children

Corticosteroids are the cornerstone of croup treatment for all severity levels, with a single oral dose of dexamethasone 0.6 mg/kg (maximum 12 mg) as the standard first-line therapy, combined with nebulized epinephrine for moderate-to-severe cases.

Primary Treatment Approach

Corticosteroids (First-Line for All Cases)

Dexamethasone is the preferred corticosteroid due to extensive evidence and longer duration of action 1, 2, 3. The standard dosing is:

  • Standard dose: 0.6 mg/kg orally (maximum 12 mg) as a single dose 1, 2, 3
  • Lower dose alternative: 0.15 mg/kg may be equally effective for mild-to-moderate croup, though evidence remains underpowered 4, 2

Key evidence: Glucocorticoids reduce croup scores at 2,6, and 12 hours compared to placebo, shorten hospital stays, and reduce return visits 2. The benefit is seen across all severity levels, including mild cases 5, 6.

Alternative corticosteroid: Prednisolone can be used if dexamethasone is unavailable, though dexamethasone reduces return visits by approximately 45% and decreases need for supplemental glucocorticoids by 28% compared to prednisolone 2.

Nebulized Epinephrine (For Moderate-to-Severe Croup)

Use nebulized epinephrine for children with significant stridor at rest, chest wall retractions, or respiratory distress:

  • Racemic epinephrine: 0.5 mL/kg of 2.25% solution (maximum 0.5 mL) diluted in 2 mL normal saline 1
  • L-epinephrine alternative: 0.5 mL/kg of 1:1000 solution (maximum 5 mL) if racemic epinephrine unavailable 1, 7

Critical caveat: Epinephrine provides temporary relief lasting only 1-2 hours 7. Children receiving epinephrine must be observed for at least 4 hours before discharge, as symptoms may recur after the medication wears off 7, 8. This medication should never be used in outpatient settings or for children about to be discharged 7.

Treatment Algorithm by Severity

Mild Croup

  • Barky cough with minimal or no stridor at rest
  • Treatment: Single dose dexamethasone 0.6 mg/kg orally
  • Observe for 2-4 hours; discharge if stable

Moderate Croup

  • Stridor at rest with mild-to-moderate retractions
  • Treatment:
    • Dexamethasone 0.6 mg/kg orally PLUS
    • Nebulized epinephrine (racemic or L-epinephrine)
    • Observe minimum 4 hours post-epinephrine 8

Severe Croup

  • Significant respiratory distress, marked retractions, agitation, or decreased level of consciousness
  • Treatment:
    • Dexamethasone 0.6 mg/kg (oral or IV)
    • Nebulized epinephrine immediately
    • Consider hospital admission
    • May require repeat epinephrine doses

Important Clinical Pitfalls

Do NOT use:

  • Nebulized steroids (e.g., budesonide 500 µg) may reduce symptoms in first 2 hours but lack long-term outcome data and are not standard of care 7
  • Antibiotics: Croup is viral; antibiotics have no role unless bacterial superinfection suspected 9
  • Cough suppressants or OTC medications: Associated with significant morbidity and mortality in young children 10

Observation requirements: The most common adherence failure is inadequate observation time after epinephrine administration 8. Ensure 4-hour minimum observation for any child receiving nebulized epinephrine.

Admission Criteria

Consider admission if:

  • Requires 3 or more doses of nebulized epinephrine 11
  • Persistent stridor or respiratory distress after treatment
  • Concerns about caregiver ability to monitor at home
  • Age less than 6 months or underlying airway abnormality

Evidence from quality improvement: Limiting admission until 3 doses of epinephrine are needed reduced admission rates by 37% without increasing revisits or readmissions 11.

Recurrent Croup

Children with recurrent episodes (≥2 per year) warrant evaluation for:

  • Underlying anatomic abnormalities (subglottic stenosis, laryngomalacia)
  • Gastroesophageal reflux disease
  • Asthma or reactive airway disease 3

Differential Diagnosis Considerations

Before confirming croup diagnosis, exclude:

  • Bacterial tracheitis (toxic appearance, high fever, lack of response to epinephrine)
  • Retropharyngeal or peritonsillar abscess
  • Foreign body aspiration
  • Epiglottitis (rare in vaccinated populations)

Radiography is unnecessary for typical croup but consider if diagnosis uncertain 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.